GELS
Gelteq Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · AU
$0.43
−3.50%Margins
Gross margin
58.8%
EBITDA margin
-1901.0%
EBIT margin
-2268.5%
Net margin
-2526.9%
FCF margin
-2198.9%
-49.9%
Return on equity
-35.2%
Return on assets
-32.9%
Return on invested capital
—
Asset turnover
-$3.8M
Cash from operations
$0.00
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025